Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Imaging Diagnosis of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36010991 | PubTator, text mining | PubMed |
| Antioxidant Therapy Significantly Attenuates Hepatotoxicity following Low Dose Exposure to Microcystin-LR in a Murine Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. | Antioxidants (Basel) | 2022 | 36009344 | PubTator, text mining | PubMed |
| A review and assessment of cyanobacterial toxins as cardiovascular health hazards. | Arch Toxicol | 2022 | 35997789 | PubTator, text mining | PubMed |
| A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity. | Sci Rep | 2022 | 35995956 | PubTator, text mining | PubMed |
| Congeners-Specific Intestinal Absorption Of Microcystins In An In Vitro 3D Human Intestinal Epithelium: The Role Of Influx/Efflux Transporters. | Front Toxicol | 2022 | 35990858 | PubTator, text mining | PubMed |
| Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. | Sci Rep | 2022 | 35986023 | PubTator, text mining | PubMed |
| Drug metabolism and drug transport of the 100 most prescribed oral drugs. | Basic Clin Pharmacol Toxicol | 2022 | 35972991 | PubTator, text mining | PubMed |
| Dynamics and determinants of human plasma bile acid profiles during dietary challenges. | Front Nutr | 2022 | 35967802 | PubTator, text mining | PubMed |
| Bile Acid-Drug Interaction via Organic Anion-Transporting Polypeptide 4C1 Is a Potential Mechanism of Altered Pharmacokinetics of Renally Excreted Drugs. | Int J Mol Sci | 2022 | 35955643 | PubTator, text mining | PubMed |
| Interactive Relationships between Intestinal Flora and Bile Acids. | Int J Mol Sci | 2022 | 35955473 | PubTator, text mining | PubMed |
| Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022. | MMWR Morb Mortal Wkly Rep | 2022 | 35951495 | PubTator, text mining | PubMed |
| Cluster Gauss-Newton method analyses of PBPK model parameter combinations of coproporphyrin-I based on OATP1B-mediated rifampicin interaction studies. | CPT Pharmacometrics Syst Pharmacol | 2022 | 35945914 | PubTator, text mining | PubMed |
| Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis. | Front Pharmacol | 2022 | 35935867 | PubTator, text mining | PubMed |
| Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT). | Support Care Cancer | 2022 | 35932318 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review). | Int J Oncol | 2022 | 35929515 | PubTator, text mining | PubMed |
| PPARα: A potential therapeutic target of cholestasis. | Front Pharmacol | 2022 | 35924060 | PubTator, text mining | PubMed |
| Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. | Exp Neurol | 2022 | 35905840 | PubTator, text mining | PubMed |
| A review on benefits of quercetin in hyperuricemia and gouty arthritis. | Saudi Pharm J | 2022 | 35903522 | PubTator, text mining | PubMed |
| Differential effects of metformin-mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial. | Clin Transl Sci | 2022 | 35899436 | PubTator, text mining | PubMed |
| Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease. | Clin Pharmacol Ther | 2022 | 35892316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=25